Essential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina

被引:171
作者
Skoura, Athanasia
Sanchez, Teresa
Claffey, Kevin
Mandala, Suzanne M.
Proia, Richard L.
Hla, Timothy
机构
[1] Univ Connecticut, Ctr Hlth, Ctr Vasc Biol, Farmington, CT USA
[2] Merck Res Labs, Rahway, NJ USA
[3] NIH, NIDDK, Genet Dis & Dev Branch, Bethesda, MD 20892 USA
关键词
D O I
10.1172/JCI31123
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Sphingosine 1-phosphate (S1P), a multifunctional lipid mediator that signals via the S1P family of G protein-coupled receptors (S1PR), regulates vascular maturation, permeability, and angiogenesis. In this study, we explored the role of SIP 2 receptor (S1P(2)R) in normal vascularization and hypoxia-triggered pathological angiogenesis of the mouse retina. S1P(2)R is strongly induced in ECs during hypoxic stress. When neonatal mice were subjected to ischemia-driven retinopathy, pathologic neovascularization in the vitreous chamber was suppressed in S1p2(-/-) mice concomitant with reduction in endothelial gaps and inflammatory cell infiltration. In addition, EC patterning and normal revascularization into the avascular zones of the retina were augmented. Reduced expression of the proinflammatory enzyme cyclooxygenase-2 (COX-2) and increased expression of eNOS were observed in the S1p2(-/-) mouse retina. S1P(2)R activation in ECs induced COX-2 expression and suppressed the expression of eNOS. These data identify the S1P(2)R-driven inflammatory process as an important molecular event in pathological retinal angiogenesis. We propose that antagonism of the S1P(2)R maybe a novel therapeutic approach for the prevention and/or treatment of pathologic ocular neovascularization.
引用
收藏
页码:2506 / 2516
页数:11
相关论文
共 64 条
[1]   Modulating sphingolipid biosynthetic pathway rescues photoreceptor degeneration [J].
Acharya, U ;
Patel, S ;
Koundakjian, E ;
Nagashima, K ;
Han, X ;
Acharya, JK .
SCIENCE, 2003, 299 (5613) :1740-1743
[2]   SUPPRESSION OF RETINAL NEOVASCULARIZATION IN-VIVO BY INHIBITION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) USING SOLUBLE VEGF-RECEPTOR CHIMERIC PROTEINS [J].
AIELLO, LP ;
PIERCE, EA ;
FOLEY, ED ;
TAKAGI, H ;
CHEN, H ;
RIDDLE, L ;
FERRARA, N ;
KING, GL ;
SMITH, LEH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (23) :10457-10461
[3]  
Brooks SE, 2001, INVEST OPHTH VIS SCI, V42, P222
[4]   Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference [J].
Chae, SS ;
Paik, JH ;
Furneaux, H ;
Hla, T .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (08) :1082-1089
[5]   Desmin ensheathment ratio as an indicator of vessel stability - Evidence in normal development and in retinopathy of prematurity [J].
Chan-Ling, T ;
Page, MP ;
Gardiner, T ;
Baxter, L ;
Rosinova, E ;
Hughes, S .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 165 (04) :1301-1313
[6]   Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression [J].
Chang, SH ;
Liu, CH ;
Conway, R ;
Han, DK ;
Nithipatikom, K ;
Trifan, OC ;
Lane, TF ;
Hla, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (02) :591-596
[7]   CHARACTERIZATION OF VASCULAR DEVELOPMENT IN THE MOUSE RETINA [J].
CONNOLLY, SE ;
HORES, TA ;
SMITH, LEH ;
DAMORE, PA .
MICROVASCULAR RESEARCH, 1988, 36 (03) :275-290
[8]   The regulation and pharmacology of endothelial nitric oxide synthase [J].
Dudzinski, DM ;
Igarashi, J ;
Greif, D ;
Michel, T .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2006, 46 :235-276
[9]   Thrombin suppresses endothelial nitric oxide synthase and upregulates endothelin-converting enzyme-1 expression by distinct pathways -: Role of Rho/ROCK and mitogen-activated protein kinase [J].
Eto, M ;
Barandiér, C ;
Rathgeb, L ;
Kozai, T ;
Joch, H ;
Yang, ZH ;
Lüscher, TF .
CIRCULATION RESEARCH, 2001, 89 (07) :583-590
[10]   Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes [J].
Forrest, M ;
Sun, SY ;
Hajdu, R ;
Bergstrom, J ;
Card, D ;
Doherty, G ;
Hale, J ;
Keohane, C ;
Meyers, C ;
Milligan, J ;
Mills, S ;
Nomura, N ;
Rosen, H ;
Rosenbach, M ;
Shei, GJ ;
Singer, II ;
Tian, M ;
West, S ;
White, V ;
Xie, J ;
Proia, RL ;
Mandala, S .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 309 (02) :758-768